Piclonidine

This classification denotes an antihypertensive agent with the molecular formula C14H17Cl2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R7P4D56J1Z, chemically known as (+-)-2-(2,6-dichloro-n-(tetrahydro-2h-pyran-2-yl)anilino)-2-imidazoline but generally known as piclonidine, which bears US NIH Compound Identifier 68914. European Medicines Agency schedules Piclonidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09811MIG. The term PICLONIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). PICLONIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piclonidine under HS 29349990 and SITC 51579. As of Q4 2014, PICLONIDINE remains the US FDA Preferred Term for this commodity. Piclonidine bears US NLM identifiers UMLS ID C1882374 and NCI Concept Code C66381. SMILES: Clc1c(N(C2OCCCC2)C2=NCCN2)c(Cl)ccc1.